OBSTRUKTİF UYKU APNE SENDROMU'NDA İNFLAMASYON
Amaç: Obstruktif uyku apne sendromu (OUAS) ve inflamasyon arasındaki ilişki tartışmalıdır. Uyku apne ve obesite farklı mekanizmalarla inflamasyonu arttırabilir. Bu çalışma uyku apnesi ve obesite ile proinflamatuar durumun ilişkisini inceledi. Metod: Toplam 133 olguya polisomnografi yapıldı. Polisomnografileri yapılarak, apne hipopne indeksi (AHI)>5 olan 112 OUAS tanılı hasta ve AHI5 olan 21 kontrol grubu birey çalışmaya dahil edildi. Kontrol grubu bireyler grup A olarak kabul edildi. Bununla birlikte OUAS tanılı hastalar VKİ’lerine göre non-obese grup (B grup) (VKİ<30) ve obese grup (C grup) (VKİ>30) olarak iki gruba ayrıldı. Bulgular: Tüm inflamatuar sitokinler (CRP, hs CRP, TNF-ά, IL-6) obez uyku apneli hastalarda kontrol grubu bireylerden anlamlı olarak daha yüksekti. İnsülin rezistansı obez uyku apneli hastalarda obez olmayan hastalardan ve kontrol grubundan daha yüksekti fakat insülin rezistansı kontrol grubu ve obez olmayan uyku apneli hastalar arasında farklı değildi. Tüm inflamatuar sitokinler pearson korelasyon analizinde VKİ ile anlamlı ilişki gösterdi. Ancak multiple varians analizinde CRP, hs CRP VKİ ile anlamlı ilişkiliyken, TNF-ά, IL-6’nın VKİ ile anlamlı ilişkisi yoktu. Tüm inflamatuar sitokinler yine bu analize göre desaturasyon indeksi ile anlamlı ilişkiliydi. Sonuç: Adipöz dokunun proinflamatuar durumun gelişiminde anahtar rol oynadığı için bu hastalarda obesite hem uyku apnesinin şiddetini arttırır hem de inflamasyonun artışını tetikler. OSAS’ın ve metabolik bozuklukların erken tespiti kardiovasküler morbidite ve mortalitenin azalmasına yardımcı olur.
THE INFLAMMATION IN OBSTRUCTIVE SLEEP APNEA SYNDROME
Aim: The association between obstructive sleep apnea syndrome (OSAS) and inflammation remains controversial. This study investigated the relationship between OSAS and obesity with proinflammatory state. Method: A total of 133 consecutive subjects who were referred for polysomnography. 112 were documented to have OSAS defined as AHI >5 and 21 control subjects with AHI<5 were selected upon polysomnography. Control group has been accepted as A group. In addition, patients with OSAS were divided into the following two groups based on the BMI as non-obese (B group) (BMI <30) and obese (C group) (BMI>30). Result: CRP, hs CRP, TNF-ά, IL-6 were significantly higher in the obese patients with OSAS than in the control group. Insulin resistance was higher in obese patients with sleep apnea than both in nonobese patients and control group but insulin resistance did not differ between control group and non-obese patients with sleep apnea. All of inflammatory cytokines showed significant associations with BMI in pearson correlation analysis. However, in multiple variance analysis, CRP, hs CRP were significant associated with BMI while TNF-ά, IL-6 were not significant associated BMI. All of inflamatory cytokines were significantly associated with desaturation index according to this analysis. Conclusion: Obesity increases both severity of sleep apnea and causes aggravate of inflammation in these patients because adipose tissue play a key role for the development of the proinflammatory state. Early detection of OSAS and metabolic dysfunction may help to decrease the cardiovascular morbidity and mortality.
___
- 1. Marshall NS, Wong KK, Phillips CL et al. Is Sleep
Apnea an Independent Risk Factor for Prevalent
and Incident Diabetes in the Busselton Health
Study?. Clin Sleep Med. 2009; 15: 15-20.
- 2. Babu AR, Herdegen J, Fogelfeld L et al. Type 2
diabetes, glycemic control, and continuous
positive airway pressure in obstructive sleep
apnea. Arch Intern Med. 2005; 165: 447-52.
- 3. Tasali E, Mokhlesi B, Van Cauter E. Obstructive
sleep apnea and type 2 diabetes: interacting
epidemics. Chest 2008; 133: 496-506.
- 4. Louis M, Punjabi N. M Effects of acute
intermittent hypoxia on glucose metabolism in
awake healthy volunteers. J Appl Physiol 2009,
106: 1538-44.
- 5. Coughlin S, Calverley P, Wilding J: Sleep
disordered breathing-a new component of
syndrome x? Obes Rev 2001; 2: 267-74.
- 6. Tkacova, R, Rizzo M, Berneis K. Therapy with
noninvasive ventilation in patients with
obstructive sleep apnoea: effects on atherogenic
lipoprotein phenotype. Med Hypotheses 2009;
73: 441-4.
- 7. Skarfors ET, Selinus I, Lithell HO. Risk factors
for developing non-insulin dependent diabetes:
a 10 year follow up of men in Uppsala. BMJ
1991; 303: 755-60.
- 8. Leinum CJ, Dopp JM, Morgan BJ. Sleepdisordered
breathing and obesity:
pathophysiology, complications, and treatment.
Nutr Clin Pract. 2009; 24: 675-87.
- 9. Lévy P, Bonsignore MR, Eckel J. Sleep, sleepdisordered
breathing and metabolic
consequences. Eur Respir J. 2009; 34: 243-60.
- 10. Matthews DR, Hosker JP, Rudenski AS et al.
Homeostasis model assessment: insulin
resistance and beta-cell function from fasting
plasma glucose and insulin concentrations in
man. Diabetologia 1985; 28 :412-9.
- 11. American Academy of Sleep Medicine. The
International Classification of Sleep Disorders, 2
nd ed: Diagnostic and Coding Manual, American
Academy of Sleep Medicine, Westchester, IL
2005.
- 12. Johns MW. A new method for measuring
daytime sleepiness: The Epworth Sleepiness
Scale. Sleep 1991; 14: 540-5.
- 13. Vgontzas AN, Papanicolaou DA, Bixler EO et al.
Sleep apnea and daytime sleepiness and
fatigue: relation to visceral obesity, insulin
resistance, and hypercytokinemia. J. Clin
Endocrinol Metab. 2000; 85: 1151-8.
- 14. Punjabi NM, Shahar E, Redline S et al. Sleepdisordered
breathing, glucose intolerance, and
insulin resistance: The Sleep Heart Health
Study. Am J Epidemiol 2004; 160: 521-30.
- 15. Peled N, Kassirer M, Shitrit D et al. The
association of OSA with insulin resistance,
inflammation and metabolic syndrome.
Respiratory Medicine 2007; 101: 1696-701.
- 16. McArdle N, Hillman D, Beilin L et al. Metabolic
Risk Factors for Vascular Disease in Obstructive
Sleep Apnea A Matched Controlled Study. Am J
Respir Crit Care Med. 2007; 175: 190-5.
- 17. Kono M, Tatsumi K, Saibara T et al. Obstructive
sleep apnea syndrome is associated with some
components of metabolic syndrome. Chest
2007; 131: 1387-92.
- 18. Punjabi NM, Sorkın JD, Katzel LI et al. Sleepdisordered
Breathing and Insulin Resistance in
Middle-aged and Overweight Men. Am J Respir
Crit Care Med 2002; 165: 677–82.
- 19. Stoohs RA, Facchini F, Guilleminault C. Insulin
resistance and sleep-disordered breathing in
healthy humans. Am J Respir Crit Care Med.
1996; 154: 170–4.
- 20. Gruber A, Horwood F, Sithole J et al.
Obstructive sleep apnoea is independently
associated with the metabolic syndrome but not
insulin resistance state. Cardiovasc Diabetol.
2006; 5: 22.
- 21. Ip MS, Lam B, Ng MM et al. Obstructive sleep
apnea is independently associated with insulin
resistance. Am J Respir Crit Care Med. 2002;
165: 670-6.
- 22. Bastard JP, Maachi M, Lagathu C et al. Recent
advances in the relationship between obesity,
inflammation, and insulin resistance. Eur
Cytokine Netw. 2006; 17: 4-12.
- 23. Torres-Leal FL, Fonseca-Alaniz MH, Rogero MM
et al. The role of inflamed adipose tissue in the
insulin resistance. Cell Biochem Funct. 2010;
28: 623-31.
- 24. Sheu WH, Chang TM, Lee WJ et al. Effect of
weight loss on proinflammatory state of
mononuclear cells in obese women. Obesity
2008; 16: 1033-8.
- 25. Iiyori N, Alonso LC, Sanders MH et al.
Intermittent hypoxia causes insulin resistance in
lean mice independent of autonomic activity.
Am J Respir Crit Care Med. 2007; 175: 851-7.
- 26. Louis M, Punjabi NM. Effects of acute
intermittent hypoxia on glucose metabolism in
awake healthy volunteers. J Appl Physiol. 2009;
106: 1538-44.
- 27. Brooks B, Cistulli PA, Borkman M et al.
Obstructive sleep apnea in obese noninsulindependent
diabetic patients: effect of
continuous positive airway pressure treatment
on insulin responsiveness. J. Clin Endocrinol
Metab. 1994; 79: 1681-5.